Evidence map›Paper›PMID 29712858›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy.

Xudong Liao, Yuyan Shen, Rongli Zhang, Keiki Sugi, Neelakantan T Vasudevan, M Amer Alaiti, David R Sweet, Lin Zhou, Yulan Qing, Stanton L Gerson and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Regenerative therapy · 2026
    Article
  5. Article
  6. Article
  7. CD163Basic research in cardiology · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Macrophage energy metabolism in cardiometabolic disease.Molecular and cellular biochemistry · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. TIMD4JACC. Basic to translational science · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Xudong LiaoCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106; xudong.liao@case.edu mukesh.jain2@case.edu.ORCID 0000-0001-8864-0755
Yuyan ShenCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106.ORCID 0000-0002-2496-3077
Rongli ZhangCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Keiki SugiCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Neelakantan T VasudevanCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
M Amer AlaitiCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
David R SweetCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Lin ZhouDepartment of Cardiology, Tongji Hospital of Tongji University, 20065 Shanghai, China.
Yulan QingCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106.
Stanton L GersonCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106.
Chen FuDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Anthony Wynshaw-BorisDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Rui HuYale Cardiovascular Research Center, Yale University, New Haven, CT 06511.
Martin A SchwartzYale Cardiovascular Research Center, Yale University, New Haven, CT 06511.
Hisashi FujiokaElectron Microscopy Core Facility, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Brian RichardsonDepartment of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Mark J CameronDepartment of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Hiroki HayashiInstitute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Jonathan S StamlerInstitute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Mukesh K JainCase Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106; xudong.liao@case.edu mukesh.jain2@case.edu.
University Hospitals of Cleveland · USUniversity School · USUniversity Hospitals Seidman Cancer Center · USYale University · USCase Western Reserve University · USDiscovery Institute · USTongji University · CN

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
KLF control of aging and age-associated cardiovascular diseaseR35HL135789 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI JAIN, MUKESH KUMAR · 2017 to 2023
$6.7M
KLF15 in skeletal muscle lipid metabolismR01DK111468 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI JAIN, MUKESH KUMAR · 2017 to 2020
$1.4M
Myeloid KLF2 mediates S-nitrosylation-driven vascular response to ischemic injuryF30HL139014 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI SWEET, DAVID RYAN · 2017 to 2020
$197k
NHLBI NIH HHS F30 HL139014NHLBI NIH HHS R35 HL135789NIAID NIH HHS P30 AI036219NIDDK NIH HHS R01 DK111468NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Nonischemic cardiomyopathy (NICM) resulting from long-standing hypertension, valvular disease, and genetic mutations is a major cause of heart failure worldwide. Recent observations suggest that myeloid cells can impact cardiac function, but the role of tissue-intrinsic vs. tissue-extrinsic myeloid cells in NICM remains poorly understood. Here, we show that cardiac resident macrophage proliferation occurs within the first week following pressure overload hypertrophy (POH; a model of heart failure) and is requisite for the heart's adaptive response. Mechanistically, we identify Kruppel-like factor 4 (KLF4) as a key transcription factor that regulates cardiac resident macrophage proliferation and angiogenic activities. Finally, we show that blood-borne macrophages recruited in late-phase POH are detrimental, and that blockade of their infiltration improves myocardial angiogenesis and preserves cardiac function. These observations demonstrate previously unappreciated temporal and spatial roles for resident and nonresident macrophages in the development of heart failure.

Indexed as

AnimalsCardiomegalyCardiomyopathiesCells, CulturedHeart FailureKruppel-Like Factor 4Kruppel-Like Transcription FactorsMacrophagesMiceMyocardiumPressureKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription Factorsangiogenesiscardiac macrophagepressure overload hypertrophy

Identifiers

PMID29712858
PMCPMC5960298
OpenAlexW2800905301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.